The blood-brain barrier protects the brain from harmful substances, but it also prevents many medicines from reaching their ...
Researchers have developed Fullscope-seq, a long-read spatial transcriptomics platform that maps alternative transcript isoforms within intact tissues at single-cell resolution - opening new ...
Insilico Medicine have announced their Drug Discovery and Development (DDD) Benchmarks as a Service (BaaS) platform offers a standardised framework for evaluating frontier AI and foundation models ...
Researchers at Texas A&M have developed AI-driven platforms to help scientists navigate the bottlenecks of tuberculosis drug ...
Researchers at the Indian Institute of Technology Gandhinagar have developed an injectable hydrogel incorporating a novel cerium-rutin metal-phenolic nanocomplex that simultaneously targets oxidative ...
Understanding where proteins are expressed throughout the body is critical for selecting better drug targets. Here's how a ...
A new study published in Science identifies a specialised dendritic cell subset as the cellular architects behind tertiary ...
A blood-based biomarker measuring amyloid beta protein misfolding has demonstrated superior predictive accuracy for ...
A landmark genome-wide study of more than 2.5 million adults has identified 26 genomic regions linked to fibromyalgia, ...
From ChatGPT to AI agents and world models, where is AI really heading in drug discovery? Dr Raminderpal Singh explains what ...
As oligonucleotide therapeutics rapidly advance, their safety profile presents challenges unlike any other drug modality.
A new review examines how physical, bioengineered and biomimetic delivery platforms that bypass conventional endocytic uptake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results